Contribution of direct and indirect recognition pathways to T cell alloreactivity

doi:10.1084/jem.177.6.1643

This Article

	Full Text (PDF, 871K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Liu, Z.
	Articles by Suciu-Foca, N.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Liu, Z.
	Articles by Suciu-Foca, N.

Social Bookmarking

	What's this?

ARTICLES

Contribution of direct and indirect recognition pathways to T cell alloreactivity

Z Liu, YK Sun, YP Xi, A Maffei, E Reed, P Harris and N Suciu-Foca
Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, New York 10032.

T cells from an HLA-DR11/DR12 responder were stimulated in mixed lymphocyte culture with cells carrying the DR1 antigen. After priming, T cells proliferated in response to both DR1-positive-stimulating cells and a peptide derived from a polymorphic region of the HLA-DR beta 1*0101 chain presented by responder's antigen-presenting cells (APC). The dominant epitope recognized by the primed T cells corresponded to residue 21-42 and was presented by the responder's HLA-DR12 antigen. The DR1 peptide-reactive T cells express T cell receptor V beta 3. The results demonstrate that allopeptides derived from the processing and presentation of donor major histocompatibility complex molecules by host-derived APC trigger alloreactivity. The frequency of T cells engaged in the indirect pathway of allorecognition is about 100-fold lower than that of T cells participating in the direct recognition of native HLA-DR antigen. However, indirect allorecognition may play an important role in chronic allograft rejection, a phenomenon that is mediated by the activation of T helper cells and of alloantibody- producing B cells.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Fehr, T., Haspot, F., Mollov, J., Chittenden, M., Hogan, T., Sykes, M. (2008). Alloreactive CD8 T Cell Tolerance Requires Recipient B Cells, Dendritic Cells, and MHC Class II. J. Immunol. 181: 165-173 [Abstract] [Full Text]
Tokita, D., Shishida, M., Ohdan, H., Onoe, T., Hara, H., Tanaka, Y., Ishiyama, K., Mitsuta, H., Ide, K., Arihiro, K., Asahara, T. (2006). Liver Sinusoidal Endothelial Cells That Endocytose Allogeneic Cells Suppress T Cells with Indirect Allospecificity. J. Immunol. 177: 3615-3624 [Abstract] [Full Text]
Kikuchi, T., Hahn, C. L., Tanaka, S., Barbour, S. E., Schenkein, H. A., Tew, J. G. (2004). Dendritic Cells Stimulated with Actinobacillus actinomycetemcomitans Elicit Rapid Gamma Interferon Responses by Natural Killer Cells. Infect. Immun. 72: 5089-5096 [Abstract] [Full Text]
Manavalan, J. S., Kim-Schulze, S., Scotto, L., Naiyer, A. J., Vlad, G., Colombo, P. C., Marboe, C., Mancini, D., Cortesini, R., Suciu-Foca, N. (2004). Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16: 1055-1068 [Abstract] [Full Text]
Mirenda, V., Berton, I., Read, J., Cook, T., Smith, J., Dorling, A., Lechler, R. I. (2004). Modified Dendritic Cells Coexpressing Self and Allogeneic Major Histocompatability Complex Molecules: An Efficient Way to Induce Indirect Pathway Regulation. J. Am. Soc. Nephrol. 15: 987-997 [Abstract] [Full Text]
Richards, D. M., Dalheimer, S. L., Ehst, B. D., Vanasek, T. L., Jenkins, M. K., Hertz, M. I., Mueller, D. L. (2004). Indirect Minor Histocompatibility Antigen Presentation by Allograft Recipient Cells in the Draining Lymph Node Leads to the Activation and Clonal Expansion of CD4+ T Cells That Cause Obliterative Airways Disease. J. Immunol. 172: 3469-3479 [Abstract] [Full Text]
Mancini, D., Pinney, S., Burkhoff, D., LaManca, J., Itescu, S., Burke, E., Edwards, N., Oz, M., Marks, A. R. (2003). Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy. Circulation 108: 48-53 [Abstract] [Full Text]
Higuchi, R., Streilein, J. W. (2003). CD8+ T Cell-Mediated Delayed Rejection of Orthotopic Guinea Pig Cornea Grafts in Mice Deficient in CD4+ T Cells. IOVS 44: 175-182 [Abstract] [Full Text]
Freese, A., Zavazava, N. (2002). HLA-B7 beta -pleated sheet-derived synthetic peptides are immunodominant T-cell epitopes regulating alloresponses. Blood 99: 3286-3292 [Abstract] [Full Text]
Najafian, N., Salama, A. D., Fedoseyeva, E. V., Benichou, G., Sayegh, M. H. (2002). Enzyme-Linked Immunosorbent Spot Assay Analysis of Peripheral Blood Lymphocyte Reactivity to Donor HLA-DR Peptides: Potential Novel Assay for Prediction of Outcomes for Renal Transplant Recipients. J. Am. Soc. Nephrol. 13: 252-259 [Abstract] [Full Text]
Tanaka, K., Sonoda, K.-h., Streilein, J. W. (2001). Acute Rejection of Orthotopic Corneal Xenografts in Mice Depends on CD4+ T Cells and Self-Antigen-Presenting Cells. IOVS 42: 2878-2884 [Abstract] [Full Text]
Pimenta-Araujo, R., Mascarell, L., Huesca, M., Cumano, A., Bandeira, A. (2001). Embryonic Thymic Epithelium Naturally Devoid of APCs Is Acutely Rejected in the Absence of Indirect Recognition. J. Immunol. 167: 5034-5041 [Abstract] [Full Text]
Lee, R. S., Yamada, K., Houser, S. L., Womer, K. L., Maloney, M. E., Rose, H. S., Sayegh, M. H., Madsen, J. C. (2001). Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc. Natl. Acad. Sci. USA 98: 3276-3281 [Abstract] [Full Text]
Slachta, C. A., Jeevanandam, V., Goldman, B., Lin, W. L., Platsoucas, C. D. (2000). Coronary Arteries from Human Cardiac Allografts with Chronic Rejection Contain Oligoclonal T Cells: Persistence of Identical Clonally Expanded TCR Transcripts from the Early Post-Transplantation Period (Endomyocardial Biopsies) to Chronic Rejection (Coronary Arteries). J. Immunol. 165: 3469-3483 [Abstract] [Full Text]
Sano, Y., Ksander, B. R., Streilein, J. W. (2000). Langerhans Cells, Orthotopic Corneal Allografts, and Direct and Indirect Pathways of T-Cell Allorecognition. IOVS 41: 1422-1431 [Abstract] [Full Text]
Beniaminovitz, A., Itescu, S., Lietz, K., Donovan, M., Burke, E. M., Groff, B. D., Edwards, N., Mancini, D. M. (2000). Prevention of Rejection in Cardiac Transplantation by Blockade of the Interleukin-2 Receptor with a Monoclonal Antibody. NEJM 342: 613-619 [Abstract] [Full Text]
Burrows, S. R., Khanna, R., Moss, D. J. (1999). Direct Alloreactivity by Human Cytotoxic T Lymphocytes Can Be Inhibited by Altered Peptide Ligand Antagonism. Blood 93: 1020-1024 [Abstract] [Full Text]
Semple, J. W., Speck, E. R., Cosgrave, D., Lazarus, A. H., Blanchette, V. S., Freedman, J. (1999). Extreme Leukoreduction of Major Histocompatibility Complex Class II Positive B Cells Enhances Allogeneic Platelet Immunity. Blood 93: 713-720 [Abstract] [Full Text]
Watschinger, B. (1999). Indirect recognition of allo MHC peptides - potential role in human transplantation. Nephrol Dial Transplant 14: 8-11
ROSSINI, A. A., GREINER, D. L., MORDES, J. P. (1999). Induction of Immunologic Tolerance for Transplantation. Physiol. Rev. 79: 99-141 [Abstract] [Full Text]
Matesic, D., Valujskikh, A., Pearlman, E., Higgins, A. W., Gilliam, A. C., Heeger, P. S. (1998). Type 2 Immune Deviation Has Differential Effects on Alloreactive CD4+ and CD8+ T Cells. J. Immunol. 161: 5236-5244 [Abstract] [Full Text]
Yamada, J., Dana, M. R., Zhu, S.-N., Alard, P., Streilein, J. W. (1998). Interleukin 1 Receptor Antagonist Suppresses Allosensitization in Corneal Transplantation. Arch Ophthalmol 116: 1351-1357 [Abstract] [Full Text]
Vallee, I., Guillaumin, J.-M., Thibault, G., Gruel, Y., Lebranchu, Y., Bardos, P., Watier, H. (1998). Human T Lymphocyte Proliferative Response to Resting Porcine Endothelial Cells Results from an HLA-Restricted, IL-10-Sensitive, Indirect Presentation Pathway But Also Depends on Endothelial-Specific Costimulatory Factors. J. Immunol. 161: 1652-1658 [Abstract] [Full Text]
Pettigrew, G. J., Lovegrove, E., Bradley, J. A., Maclean, J., Bolton, E. M. (1998). Indirect T Cell Allorecognition and Alloantibody-Mediated Rejection of MHC Class I-Disparate Heart Grafts. J. Immunol. 161: 1292-1298 [Abstract] [Full Text]
Itescu, S., Burke, E., Lietz, K., John, R., Mancini, D., Michler, R., Rose, E., Oz, M., Edwards, N. (2002). Intravenous Pulse Administration of Cyclophosphamide Is an Effective and Safe Treatment for Sensitized Cardiac Allograft Recipients. Circulation 105: 1214-1219 [Abstract] [Full Text]